Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II sorafenib monotherapy in relapsed high-grade osteosarcoma
2007-004396-19Phase 2Completed
- Sponsor
- Italian Sarcoma Group
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in osteosarcoma (OS), sponsored by Italian Sarcoma Group. Primary endpoint: Percentage of patients progression free at 4 months. Started Mar 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on 2007-004396-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004396-19.